31 Mar 2023

Reference: CIR-2023-00000044

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

Safety update of pharmaceutical product Bemiparin

Safety update of pharmaceutical product Omeprazole

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

اضافة تحذير على المنتج الطبي - Bemiparin ---.pdf

download

اضافة تحذير على المنتج الطبي -Omeprazole ==.pdf

download